The elevation of circulating fibroblast growth factor 23 without kidney disease does not increase cardiovascular disease risk

Fiji: an open-source platform for biological-image analysis

Johannes Schindelin, Ignacio Arganda‐Carreras, Erwin Frise et al. · Nature Methods · 2012 · 70.9K citations

Engineering, Bioinformatics, Biology +9

Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization

Alan S. Go, Glenn M. Chertow, Dongjie Fan et al. · New England Journal of Medicine · 2004 · 11.4K citations · Full text

Medicine, Internal Medicine, Nephrology +14

Prognostic Implications of Echocardiographically Determined Left Ventricular Mass in the Framingham Heart Study

Daniel Levy, Robert J. Garrison, Daniel D. Savage et al. · New England Journal of Medicine · 1990 · 5.7K citations · Full text

Medicine, Cardiology, Internal Medicine +17

FGF23 induces left ventricular hypertrophy

Christian Faul, Ansel P. Amaral, Behzad N. Oskouei et al. · Journal of Clinical Investigation · 2011 · 2K citations

Life Sciences, Cardiology, Molecular Biology +14

Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease

Tamara Isakova, Patricia Wahl, Gabriela Vargas et al. · Kidney International · 2011 · 1.2K citations · Full text

Medicine, Endocrinology, Nephrology +16